The report maintains ADD on Mphasis with revised TP of INR 2,860, citing its strongest sequential growth in three years, record deal pipeline, and raised FY27 revenue growth guidance to low double digits.
Read this note →MphasiS Limited
NSE MPHASIS BSE 526299 INE356A01018
0 filings · 0 analysed
2,455.00
+14.52%
over 6 months
-
HSIE Results Daily 07 Nov 26 HSIE
The report maintains ADD on Mphasis with revised TP of INR 2,860, citing its strongest sequential growth in three years, record deal pipeline, and raised FY27 revenue growth guidance to low double digits.
-
Daily Derivative and Technical snapshot 23 10 2026
The report notes Mphasis saw short buildup with OI change of 13.05% and price down 2.54%.
-
The report notes Mphasis filed 132 PERM applications in FY25 and was not among the suspended firms.
-
The note says Mphasis extended its partnership with Social Security Scotland in a deal worth ~GBP 35.4mn (~2.84% of FY26 revenues), which it says provides strong revenue visibility and deepens its UK public-sector presence.
-
The note says Mphasis will extend its collaboration with Social Security Scotland to manage and maintain its benefits management platform.
-
The note cites a forecast of 3.5% sequential growth for Mphasis in Q2 FY27.
-
The report expects Mphasis to grow +3.5% QoQ CC on continued BFSI ramp-up and names it a mid-tier preference, raising the target price to INR 2,840.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 07 Nov 2026, 06:48 | long | 2,520.00 | 2,860.00 | — | — | open by 2027-11-07 |
| HDFC Securities | 01 Oct 2026, 16:10 | long | 2,250.20 | 2,840.00 | 2,520.00 | 46% | open by 2027-10-01 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report notes Mphasis saw short buildup with OI change of 13.05% and price down 2.54%.
Read this note →The report notes Mphasis filed 132 PERM applications in FY25 and was not among the suspended firms.
Read this note →The note says Mphasis extended its partnership with Social Security Scotland in a deal worth ~GBP 35.4mn (~2.84% of FY26 revenues), which it says provides strong revenue visibility and deepens its UK public-sector presence.
Read this note →The note says Mphasis will extend its collaboration with Social Security Scotland to manage and maintain its benefits management platform.
Read this note →The note cites a forecast of 3.5% sequential growth for Mphasis in Q2 FY27.
Read this note →The report expects Mphasis to grow +3.5% QoQ CC on continued BFSI ramp-up and names it a mid-tier preference, raising the target price to INR 2,840.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief